Cloning and functional analysis of human acyl coenzyme A: Cholesterol acyltransferase1 gene P1 promoter

Ge,Jing; Cheng,Bei; Qi,Benling; Peng,Wen; Wen,Hui; Bai,Lijuan; Liu,Yun; Zhai,Wei

doi:10.3892/mmr.2016.5295

Cloning and functional analysis of human acyl coenzyme A: Cholesterol acyltransferase1 gene P1 promoter

Authors:
- Jing Ge
- Bei Cheng
- Benling Qi
- Wen Peng
- Hui Wen
- Lijuan Bai
- Yun Liu
- Wei Zhai
View Affiliations

Affiliations: Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China, Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China
Published online on: May 18, 2016 https://doi.org/10.3892/mmr.2016.5295
Pages: 831-838

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acyl-coenzyme A: cholesterol acyltransferase 1 (ACAT1) catalyzes the conversion of free cholesterol (FC) to cholesterol ester. The human ACAT1 gene P1 promoter has been cloned. However, the activity and specificity of the ACAT1 gene P1 promoter in diverse cell types remains unclear. The P1 promoter fragment was digested with KpnI/XhoI from a P1 promoter cloning vector, and was subcloned into the multiple cloning site of the Firefly luciferase vector pGL3‑Enhancer to obtain the construct P1E‑1. According to the analysis of biological information, the P1E‑1 plasmid was used to generate deletions of the ACAT1 gene P1 promoter with varying 5' ends and an identical 3' end at +65 by polymerase chain reaction (PCR). All the 5'‑deletion constructs of the P1 promoter were identified by PCR, restriction enzyme digestion mapping and DNA sequencing. The transcriptional activity of each construct was detected after transient transfection into THP‑1, HepG2, HEK293 and Hela cells using DEAE‑dextran and Lipofectamine 2000 liposome transfection reagent. Results showed that the transcriptional activity of the ACAT1 gene P1 promoter and deletions of P1 promoter in THP‑1 and HepG2 cells was higher than that in HEK293 and HeLa cells. Moreover, the transcriptional activity of P1E‑9 was higher compared with those of other deletions in THP‑1, HepG2, HEK293 and HeLa cells. These findings indicate that the transcriptional activity of the P1 promoter and the effects of deletions vary with different cell lines. Thus, the P1 promoter may drive ACAT1 gene expression with cell‑type specificity. In addition, the core sequence of ACAT1 gene P1 promoter was suggested to be between -125 and +65 bp.

View Figures

View References

1	Tabas I: The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages. Curr Opin Lipidol. 6:260–268. 1995. View Article : Google Scholar : PubMed/NCBI
2	Chang CC, Sakashita N, Ornvold K, Lee O, Chang ET, Dong R, Lin S, Lee CY, Strom SC, Kashyap R, et al: Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem. 275:28083–28092. 2000.PubMed/NCBI
3	Lee O, Chang CC, Lee W and Chang TY: Immunodepletion experiments suggest that acyl-coenzyme A: Cholesterol acyl-transferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages, and kidney, but not in intestines. J Lipid Res. 39:1722–1727. 1998.PubMed/NCBI
4	Sakashita N, Miyazaki A, Takeya M, Horiuchi S, Chang CC, Chang TY and Takahashi K: Localization of human acyl-coenzyme A: Cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues. Am J Pathol. 156:227–236. 2000. View Article : Google Scholar : PubMed/NCBI
5	Saraon P, Trudel D, Kron K, Dmitromanolakis A, Trachtenberg J, Bapat B, van der Kwast T, Jarvi KA and Diamandis EP: Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression. Prostate. 74:372–380. 2014. View Article : Google Scholar
6	Murphy SR, Chang CC, Dogbevia G, Bryleva EY, Bowen Z, Hasan MT and Chang TY: Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer's disease. Mol Ther. 21:1497–1506. 2013. View Article : Google Scholar : PubMed/NCBI
7	Dharuri H, 't Hoen PA, van Klinken JB, Henneman P, Laros JF, Lips MA, El Bouazzaoui F, van Ommen GJ, Janssen I, van Ramshorst B, et al: Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss. Diabetologia. 57:2384–2392. 2014. View Article : Google Scholar : PubMed/NCBI
8	Li BL, Li XL, Duan ZJ, Lee O, Lin S, Ma ZM, Chang CC, Yang XY, Park JP, Mohandas TK, et al: Human acyl-coA: Cholesterol acyltransferase-1 (ACAT-1) gene organization and evidence that the 4.3-Kilobase ACAT-1 mRNA is produced from two different chromosomes. J Biol Chem. 274:11060–11071. 1999. View Article : Google Scholar : PubMed/NCBI
9	Ge J, Zhai W, Cheng B, He P, Qi B, Lu H, Zeng Y and Chen X: Insulin induces human acyl-coenzyme A: Cholesterol acyl-transferase 1 gene expression via MAP kinases and CCAAT/enhancer-binding protein α. J Cell Biochem. 114:2188–2198. 2013. View Article : Google Scholar : PubMed/NCBI
10	Yang JB, Duan ZJ, Yao W, Lee O, Yang L, Yang XY, Sun X, Chang CC, Chang TY and Li BL: Synergistic transcriptional activation of human Acyl-coenzyme A: Cholesterol acyltransterase-1 gene by interferon-gamma and all-trans-retinoic acid THP-1 cells. J Biol Chem. 276:20989–20998. 2001. View Article : Google Scholar : PubMed/NCBI
11	Chang TY, Chang CC and Cheng D: Acyl-coenzyme A: Cholesterol acyltransferase. Annu Rev Biochem. 66:613–638. 1997. View Article : Google Scholar
12	Yang L, Yang JB, Chen J, Yu GY, Zhou P, Lei L, Wang ZZ, Cy Chang C, Yang XY, Chang TY and Li BL: Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone. Cell Res. 14:315–323. 2004. View Article : Google Scholar : PubMed/NCBI
13	Maung K, Miyazaki A, Nomiyama H, Chang CC, Chang TY and Horiuchi S: Induction of acyl-coenzyme A: Cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D(3) or 9-cis-retinoic acid in undifferentiated THP-1 cells. J Lipid Res. 42:181–187. 2001.PubMed/NCBI
14	Lei L, Xiong Y, Chen J, Yang JB, Wang Y, Yang XY, Chang CC, Song BL, Chang TY and Li BL: TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation. J Lipid Res. 50:1057–1067. 2009. View Article : Google Scholar : PubMed/NCBI
15	Hori M, Miyazaki A, Tamagawa H, Satoh M, Furukawa K, Hakamata H, Sasaki Y and Horiuchi S: Up-regulation of acyl-coenzyme A: Cholesterol acyltransferase-1 by transforming growth factor-beta1 during differentiation of human monocytes into macrophages. Biochem Biophys Res Commun. 320:501–505. 2004. View Article : Google Scholar : PubMed/NCBI
16	Suguro T, Watanabe T, Kanome T, Kodate S, Hirano T, Miyazaki A and Adachi M: Serotonin acts as an up-regulator of acyl-coenzyme A: Cholesterol acyltransferase-1 in human monocyte-macrophages. Atherosclerosis. 186:275–281. 2009. View Article : Google Scholar
17	Hongo S, Watanabe T, Arita S, Kanome T, Kageyama H, Shioda S and Miyazaki A: Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages. Am J Physiol Endocrinol Metab. 297:E474–E482. 2009. View Article : Google Scholar : PubMed/NCBI
18	Nagashima M, Watanabe T, Terasaki M, Tomoyasu M, Nohtomi K, Kim-Kaneyama J, Miyazaki A and Hirano T: Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia. 54:2649–2459. 2011. View Article : Google Scholar : PubMed/NCBI
19	Zhao ZZ, Wang Z, Li GH, Wang R, Tan JM, Cao X, Suo R and Jiang ZS: Hydrogen sulfide inhibits macrophage-derived foam cell formation. Exp Biol Med (Maywood). 236:169–176. 2011. View Article : Google Scholar
20	Furukawa K, Hori M, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Miyazaki A, Nakayama H and Horiuchi S: Adiponectin down-regulates acyl-coenzyme A: Cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages. Biochem Biophys Res Commun. 317:831–836. 2004. View Article : Google Scholar : PubMed/NCBI
21	Wan JJ, Cheng B, Wang YF, Mei CL, Liu W, Ke L and He P: Ghrelin down-regulates ACAT-1 in THP-1 derived foam cells via growth hormone secretagogue receptor-dependent pathway. Zhonghua Xin Xue Guan Bing Za Zhi. 37:1030–1034. 2009.In Chinese.
22	Smith JL, Rangaraj K, Simpson R, Maclean DJ, Nathanson LK, Stuart KA, Scott SP, Ramm GA and de Jersey J: Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. J Lipid Res. 45:686–696. 2004. View Article : Google Scholar : PubMed/NCBI